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Abstract
Background: Risk factors in childhood create a life-long burden important in the development of
cardiovascular (CV) disease in adulthood. Many risk factors for CV disease (e.g., hypertension) also
increase the risk of renal disease. However, the importance of childhood risk factors on the
development of chronic kidney disease and end-stage renal disease (ESRD) is not well
characterized.
Methods: The current observations include data from Bogalusa Heart Study participants who
were examined multiple times as children between 1973 and 1988.
Results: Through 2006, fifteen study participants subsequently developed ESRD in adulthood;
seven with no known overt cause. Although the Bogalusa Heart Study population is 63% white and
37% black and 51% male and 49% female, all seven ESRD cases with no known overt cause were
black males (p < 0.001). Mean age-adjusted systolic and diastolic blood pressure in childhood was
higher among the ESRD cases (114.5 mmHg and 70.1 mmHg, respectively) compared to black
(103.0 mmHg and 62.3 mmHg, respectively) and white (mean = 103.3 mmHg and 62.3 mmHg,
respectively) boys who didn't develop ESRD. The mean age-adjusted body mass index in childhood
was 23.5 kg/m2 among ESRD cases and 18.6 kg/m2 and 18.9 kg/m2 among black and white boys who
didn't develop ESRD, respectively. Plasma glucose in childhood was not significantly associated with
ESRD.
Conclusion: These data suggest black males have an increased risk of ESRD in young adulthood.
Elevated body mass index and blood pressure in childhood may increase the risk for developing
ESRD as young adults.
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Background
There are multiple underlying causes of chronic kidney
disease leading to end-stage renal disease (ESRD). How-
ever, there are few long term observations on risk factors
in childhood for ESRD in adulthood. Such observations
are important from the standpoint of prevention as the
number of patients with ESRD treated with renal replace-
ment therapy, dialysis or transplantation, has been
increasing in the US and worldwide [1,2]. The number of
incident and prevalent ESRD cases in the US is projected
to rise from 93,000 and 382,000, respectively, in 2000 to
136,000 and 712,000, respectively, by 2015 [3]. There-
fore, understanding the early natural history of ESRD is of
considerable interest.
Epidemiologic studies have demonstrated that cardiovas-
cular (CV) risk factors, such as hypertension and diabetes
mellitus, are identifiable in childhood and are predictive
atherosclerotic vascular disease in adulthood [4-8].
Autopsy studies in youth have also established a strong
association between CV risk factors and early stages of cor-
onary atherosclerosis [9-13]. These observations have also
shown renal vasculature to be involved at a young age.
Our autopsy studies [9-12] and the earlier work of Folkow
et al [14] readily showed "adaptive structural changes of
the vascular walls in hypertension" that can be occurring
in youth and influence vascular resistance[15]. In addi-
tion, non-invasive studies of structure/function of the CV
system are now able to show subtle changes begin in
childhood that are strongly associated with clinical CV
risk factors.
In adults, multiple CV risk factors are known to be associ-
ated with the development of renal disease [16-19]. How-
ever, few observations have been made on the association
of such factors measured in childhood with the develop-
ment of ESRD in young adulthood. The purpose of the
current study is to note determinants obtained through a
general risk factor screenings in childhood, adolescence
and young adulthood with the occurrence of ESRD in
young adulthood.
Methods
Study Population
The Bogalusa Heart Study, beginning in 1973, consists of
multiple cross-sectional examinations of children residing
in the bi-racial (65 percent white, 35 percent black) com-
munity of Bogalusa, Louisiana[8]. These individuals were
followed by screening into young adulthood. The current
study cohort includes those who participated in at least
one examination as a child in 1973-1974 (n = 3865),
1975-1976 (n = 4222), 1981-1982(n = 2832), 1984-
1985(n = 2149), and1987-1988 (n = 2582). The vast
majority of participants were less than 18 years of age at
baseline with only 28 participants ≥ 20 years of age. For
participants with multiple examinations, data from vari-
ous visits will be presented along with extended data
obtained from clinic records at the community public
hospital.
General Examination
As described elsewhere, all Bogalusa Heart Study examina-
tions followed the same protocols and procedures[8,20].
Interview data collected in the study visits included demo-
graphic questions and a medical history. Of relevance to
the current analysis, each participant was asked whether
they had been previously diagnosed with diabetes melli-
tus or kidney disease. Height and weight were measured
twice to the nearest 0.1 cm and 0.1 kg, respectively, and
averaged for analysis. Body mass index (BMI) was calcu-
lated using weight in kilograms divided by height in
meters squared. Three replicate systolic and diastolic
blood pressure readings were measured by each of two
randomly assigned trained observers using mercury
sphygmomanometers on the right arm of participants in a
relaxed sitting position. Average values of the six measure-
ments were used for analyses. The fourth Korotkoff phase
was used for diastolic blood pressure for children.
Identification of end-stage renal disease cases
Initially, a listing of Bogalusa Heart Study participants was
provided to the medical director of the dialysis clinic in
Bogalusa, Louisiana. Eleven cases were identified. Also, a
listing of the names, sex, date of birth, and the home
address at the time of their Bogalusa Heart Study visit was
provided to research staff at the United States Renal Data
System (USRDS). The USRDS is a registry of all patients
initiating treatment for ESRD in the United States. Unfor-
tunately, social security numbers, all changes of names
and addresses over the interval of the study were not avail-
able to facilitate matching to the USRDS. However, three
additional ESRD cases and one from the local public hos-
pital were identified resulting in 15 ESRD cases who orig-
inally participated in the Bogalusa Heart Study in
childhood.
Bogalusa Heart Study participants gave informed consent
at each examination. For those under 18 years of age, con-
sent of a parent/guardian was obtained. Study protocols
were approved by the Institutional Review Boards of the
Louisiana State University and Tulane University Health
Sciences Center.
Statistical Methods
Characteristics of the Bogalusa Heart Study participants
were recorded for each study visit included in the current
analyses. These parameters include age, race, sex, systolic
and diastolic blood pressure, height, weight, BMI, plasma
glucose, and a previous diagnosis of diabetes mellitus and
kidney disease.BMC Nephrology 2009, 10:40 http://www.biomedcentral.com/1471-2369/10/40
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Although cut-points for defining high blood pressure and
high BMI are available for children, since these variables
vary at different age periods and growth of child, we used
age-sex-height specific percentiles for blood pressure and
age-sex percentiles for BMI from each Bogalusa Heart
Study visit the subjects attended. Of the ESRD cases iden-
tified, seven (all black males) had no specific or obvious
etiologic cause of renal disease during childhood. The age-
adjusted mean systolic and diastolic blood pressure, BMI,
and plasma glucose were calculated and compared for
cases and white and black male Bogalusa Heart Study par-
ticipants who did not develop ESRD, separately, using
generalized estimating equations accounting for multiple
study visits attended. Statistical analyses were conducted
using SAS 9.1 (Cary, NC).
Results
As shown in Table 1, at the Bogalusa Heart Study visits
included in the current analysis, on average children were
11.4 years of age, 37% were black, and 49% were females.
In childhood, mean systolic and diastolic blood pressure
were 102.7 mmHg and 63.0 mmHg, respectively, the
mean BMI was 18.7 kg/m2, and the mean plasma glucose
was 84.1 mg/dL. A diagnosis of diabetes and kidney dis-
ease was reported for 1.7% and 1.3% of children, respec-
tively, at their Bogalusa Heart Study visit.
Table 2 shows observations of the fifteen Bogalusa Heart
Study participants who were identified as having devel-
oped ESRD. Four children reported having diabetes or
kidney disease at their Bogalusa Heart Study visit and an
additional four ESRD cases had a known causes of ESRD
based on the review of their hospital chart. For the seven
presumably "healthy" black males during childhood who
developed ESRD the associated study population was
comprised of 37% black, 49% male and 19% black and
male, respectively. Given this race-sex distribution, the
probability of all seven ESRD cases being black is p <
0.001, male is p = 0.007, and black males is p < 0.001.
Of the seven ESRD cases with unknown etiology, as chil-
dren, four had a BMI at or above their age-sex specific 80th
percentile during at least one of their Bogalusa Heart
Study visits. Additionally, six of the seven ESRD cases had
a systolic blood pressure or diastolic blood pressure above
their age-sex-height specific 80th percentiles at one or
more of their Bogalusa Heart Study visits. Finally, six of
the seven ESRD cases had a plasma glucose measurement
at or above their age-sex-height specific 80th percentile.
The seven ESRD cases with an unknown etiology during
childhood attended 20 Bogalusa Heart Study visits
throughout their childhood. The mean age of the cases
Table 1: Characteristics of Bogalusa Heart Study childhood participants, overall and by Bogalusa Heart Study visit.
Overall Year of Bogalusa Heart Study visit
Mean (SD) 1972-1973
(n = 3865)
1975-1976
(n = 4222)
1980-1981
(n = 3705)
1982-1983
(n = 3430)
1985-1986
(n = 2666)
Mean age, years 11.4 (3.6) 10.6 (3.1) 11.7 (3.9) 11.3 (3.8) 11.0 (3.7) 13.0 (2.8)
% black 37.0 37.1 35.9 37.1 38.2 37.0
% female 48.8 47.1 48.2 48.9 49.8 50.5
Mean SBP, mmHg 102.7 (11.0) 100.6 (10.1) 101.7 (11.3) 103.5 (11.2) 103.2 (10.8) 105.9 (10.6)
Mean DBP, mmHg 63.0 (9.0) 62.7 (8.1) 62.1 (10.1) 63.7 (8.6) 63.3 (8.6) 63.7 (8.7)
Mean height, 
centimeters
145.0 (20.0) 141.2 (18.9) 145.6 (20.9) 143.7 (20.6) 142.8 (20.5) 154.0 (15.0)
Mean weight, 
kilograms
41.4 (17.5) 37.2 (15.2) 41.9 (17.6) 40.5 (17.5) 40.2 (17.6) 49.5 (17.0)
Mean body mass 
index, kg/m2
18.7 (4.0) 17.8 (3.5) 18.7 (3.9) 18.6 (3.9) 18.7 (4.0) 20.3 (4.5)
Plasma glucose, mg/dL 84.1 (10.3) *** 88.8 (11.9) 81.3 (9.5) 79.9 (7.6) 85.2 (9.3)
% with diabetes 1.7 4.2 1.1 0.2 0.2 0.2
% with kidney disease 1.3 1.2 0.2 0.9 0.3 0.3B
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Table 2: Characteristics of Bogalusa Heart Study participants who developed end-stage renal disease (ESRD) in adulthood
STUDY AGE AT AGE AT BMI SBP/DBP GLUCOSE COMORBID CONDITIONS
# SEX RACE VISIT YEAR VISIT HEMODIALYSIS (percentile)* (percentile)* (percentile)*
Participants with unknown ESRD etiology
1 MALE BLACK 1977 12 26 (95) 104/68 (42/93) 93 (62)
1979 14 30 (98) 115/75 (59/76) 76 (20) SMOKING
1981 16 36 (99) 127/85 (91/94) 94 (96)
1989 24 34 36 (95) 136/88 (99/97) 81 (52) HYPERTENSION
2 MALE BLACK 1973 7 14 (8) 90/37 (30/1)
1975 9 14 (7) 90/40 (27/5) 3 + PROTEINURIA
1977 10 15(11) 90/44 (17/3) 99 (92)
1979 13 38 15 (3) 99/64 (46/68) 83 (50)
3 MALE BLACK 1973 13 18 (44) 133/92 
(100/100)
1977 17 22 (63) 135/84 
(100/100)
102 (92) SMOKING
1989 29 25 (59) 137/95 (99/99)
1995 35 25 (35) 162/109 
(100/100)
81 (61)
2002 42 43 28 (55) 184/134 
(100/100)
76 (23)
4 MALE BLACK 1974 11 18 (62) 135/77 
(100/100)B
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1979 16 21 (61) 139/92 
(100/100)
72 (14)
1986 23 23 (48) 118/77 (81/84) 75 (15)
1988 25 23 (41) 120/71 (81/51) 74 (20)
1996 33 37 23 (16) 120/69 (64/33)
5 MALE BLACK 1974 11 25 (95) 118/66 (95/68)
1977 14 28 (94) 112/59 (66/11) 101 (80)
1979 16 Not available 32 (97) 132/82 (98/92) 84 (57) SMOKING, OBESITY
6 MALE BLACK 1973 13 15 (52) 132/78 (83/55)
1977 17 18 (38) 114/74 (42/74) 82 (14) SMOKING
1985 25 31 (93) 118/70 (83/52) 78 (29)
1989 29 35 (93) 138/79 (99/83) 90 (85)
1996 36 46 (99) 132/94 (95/98) 75 (33)
2001 41 44 25 (28) 113/70 (65/62) 85 (61)
7 MALE BLACK 1977 8 18 (85) 107/68 (93/91) 91 (77)
1979 10 21 (85) 104/66 (81/97) 97 (95)
1982 16 22 (80) 117/75 (95/80) 80 (40)
1984 18 25 (84) 129/77 (96/83) 83 (35)
1988 22 Not available 25 (55) 118/80 (77/87) 76 (27)
Table 2: Characteristics of Bogalusa Heart Study participants who developed end-stage renal disease (ESRD) in adulthood (Continued)B
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Participants with renal disease or diabetes during study visit in childhood
8 FEMALE BLACK 1976 11 17 (46) 100/62 (20/21) 345 (100) DIABETES
1979 14 22 (66) 113/88 (70/100) 275 (100)
1989 24 39 22 (30) 98/68 (9/37) 413 (100) SMOKING, OBESITY
9 FEMALE BLACK 1974 6 20 (97) 115/70 (100/98)
1977 9 25 (97) 109/64 (91/75)
1979 11 28 (98) 110/71 (80/87) 81 (64) SEVERE KIDNEY DISEASE, 
SMOKING
1982 14 35 (98) 122/63 (95/43) 82 (50)
1989 21 37 (96) 113/65 (60/20) 257 (100)
1995 27 34 35 (87) 108/74 (45/77) 318 (100)
10 MALE WHITE 1973 7 20 (95) 102/64 (86/80)
1989 23 33 24 (49) 104/74 (24/65) 359 (100) DIABETES
11 MALE BLACK 1973 9 15 (19) 95.3/65 (44/80) HEART DISEASE, KIDNEY 
DISEASE
1977 13 20 (64) 107/77 (81/98) 86 (23) SEVERE KIDNEY DISEASE
1979 15 26 (90) 117/84 (96/100) 85 (29)
1984 20 21 (6) 134/80 (100/98) 84 (31)
1989 25 23 (37) 145/80 (100/85) 93 (91) HBP
2002 38 46 22 (11) 83 (53) GLOMERULONEPHRITIS, 
RHEUMATIC FEVER
Table 2: Characteristics of Bogalusa Heart Study participants who developed end-stage renal disease (ESRD) in adulthood (Continued)B
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Participants with other causes of renal disease
12 FEMALE BLACK 1981 5 16 (19) 103/63 (44/26) 75 (51)
1983 7 16 (10) 95/52 (26/56) 77 (83)
1987 11 17 (9) 107/57 (27/58) 82 (57)
1992 16 26 (88) 127/74 (99/92) 74 (12) LUPUS
20
13 MALE WHITE 1974 16 27 (90) 126/77 (90/92) SMOKING
40 CONGENITAL SINGLE KIDNEY
14 MALE WHITE 1973 15 31 (97) 127/79 (93/93)
1977 18 29 (93) 111/64 (37/25) 95 (71)
1989 30 30 (83) 150/99 
(100/100)
86 (73) TREATMENT FOR 
HYPERTENSION
2002 43 34 (82) 123/82 (72/82) 95 (85)
39 GLOMERULONEPHRITIS, RENAL 
MALIGNANCY
15 FEMALE BLACK 1974 13 22 (74) 110/66 (69/48)
1977 16 25 (81) 119/73 (80/55) 88 (11)
1985 24 21 (32) 136/95 
(100/100)
75 (16) HIV
1988 27 20 (11) 138/117 
(99/100)
88 (80) TREATMENT FOR 
HYPERTENSION
* Percentiles derived from children of similar age during the same study visit
Table 2: Characteristics of Bogalusa Heart Study participants who developed end-stage renal disease (ESRD) in adulthood (Continued)BMC Nephrology 2009, 10:40 http://www.biomedcentral.com/1471-2369/10/40
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was 13.3 and 11.4 and 11.9 years for white and black non-
cases, respectively (Table 3). The age-adjusted mean systo-
lic and diastolic blood pressure and BMI were each signif-
icantly higher among the cases when compared both with
white and black non-cases, separately (each p < 0.001). In
contrast, no statistically significant differences were
present in the age-adjusted mean plasma glucose between
cases and non-cases.
Discussion
Cardiovascular disease risk factors have been associated
with the development of renal disease in adults and the
association of hypertension and obesity with CV target
organ damage is now well recognized. Previous data from
the Bogalusa Heart Study have demonstrated the impor-
tance of elevated blood pressure and BMI in childhood as
predictors for the development of CV disease in adult-
hood[8,21-25]. The current study synthesizes these con-
cepts by studying children who participated in the
Bogalusa Heart Study and subsequently developed ESRD
in adulthood. The occurrence of a selective preponderance
of black males among ESRD cases with unknown etiology
is highly unusual. Also, in the current study, a majority of
the fifteen Bogalusa Heart Study participants identified as
having developed ESRD in adulthood had elevated blood
pressure and a high BMI in childhood but more of the
causal or associated factors for driving black males partic-
ularly into ESRD needs to be elucidated. It is of interest
that our autopsy studies showed medial thickening in
small renal arteries (50-400 mm)[10,12] and renal vessel
intima media changes that related to blood pressure levels
by Tracy et al[26] all beginning at a young age, Folkow et
al[14] years earlier pointed out that "adoptive structural
changes of the vascular walls in hypertension are likely
related to control of peripheral resistance". Since black
children already have higher blood pressure levels, such
renal artery changes might be expected to occur earlier in
blacks[8,27].
Almost all patients with ESRD have hypertension.
Whether hypertension precedes, or is a consequence of
underlying renal disease still remains debatable. How-
ever, several longitudinal cohort studies have identified
high blood pressure as a risk factor for the development
and progression of renal dysfunction [28-31]. For exam-
ple, using prospective follow-up from the Systolic Hyper-
tension in the Elderly Program, Young and colleagues
reported higher systolic blood pressure among older
adults to be associated with a decline in kidney function
(a rise in serum creatinine ≥0.4 mg/dl)[30]. More relevant
to the current study, blood pressure has long been
reported to be a risk factor for incident ESRD. Hsu and col-
leagues reported a strong graded relationship between
higher blood pressure and ESRD risk among 316,675 men
and women enrolled in the Kaiser Pemanente health plan
of Northern California during 35 years of follow up[31].
Specifically, compared with adult patients, who had a
systolic/diastolic blood pressure less than 120/80 mm Hg,
the multivariate adjusted relative risks (95% confidence
interval) for developing ESRD were 1.62 (1.27, 2.07),
1.98 (1.55, 2.52), 2.59 (2.07, 3.25), 3.86 (3.00, 4.96),
3.88 (2.82, 5.34), and 4.25 (2.63, 6.86) for their counter-
parts with a systolic/diastolic blood pressure of 120-129/
80-84 mm Hg, 130-139/85-89 mm Hg, 140-159/90-99
mm Hg, 160-179/100-109 mm Hg, 180-209/110-119
mm Hg, and ≥210/120 mmHg. Even in the prehyperten-
sive range[32,33], there is a projected increased risk of
ESRD. The current study extends the previous findings in
adults and shows childhood blood pressure at higher per-
centile levels, especially among black males, increases the
risk of ESRD in young adulthood.
Diabetes mellitus in adults is also a major contributor to
ESRD[34]. Also, with increasing obesity present in chil-
dren, its role also has to be considered. BMI is an estab-
lished risk factor for insulin resistance, the metabolic
syndrome, diabetes mellitus and hypertension. Obesity in
childhood is also associated with elevated blood pressure
and adverse changes of CV risk factors, including changes
in carbohydrate-insulin metabolism, especially in young
white children. Thus, obesity is a major contributor to
increase the risk of adult CV disease and ESRD [35-37].
The multivariable-adjusted relative risk for ESRD illus-
trated in the aforementioned study of Kaiser Permanente
enrollees, compared with persons who had normal weight
(BMI, 18.5 to 24.9 kg/m2), was 1.87 (95% CI, 1.64,
2.14),3.57 (3.05, 4.18), 6.12 (CI, 4.97, 7.54), and 7.07
(CI, 5.37, 9.31) for those with a BMI of 25.0 to 29.9 kg/
m2, 30.0 to 34.9 kg/m2, 35.0 to 39.9 kg/m2, and ≥40 kg/
m2. In the current study, BMI was significantly higher in
children who later developed, compared to their counter-
parts who did not develop, ESRD. With regards to the CV
problems, we have previously shown that BMI in child-
hood is the most consistent predictor of left ventricular
mass and left ventricular dilatation in young adult-
hood[23,24]. The role of obesity may be through its met-
abolic pathway for hormonal, and inflammatory
adipokine factors that influence renal structure and func-
tional integrity, as well as hemodynamic factors noted for
heart disease.
The occurrence of all seven ESRD cases of primarily
unknown etiology being black males in a bi-racial cohort
(63% white and 37% black) with an approximately equal
gender distribution represents an unusual probability.
However, this finding is consistent from US population
data where the incidence of ESRD is more than 4-fold
higher among young black, compared to white, US adults.BMC Nephrology 2009, 10:40 http://www.biomedcentral.com/1471-2369/10/40
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In 2006, the last for which data are available, the inci-
dence rate of ESRD among young US adults (20 to 39
years of age) was 341.7 and 265.3 for black males and
females, respectively, and 79.8 and 57.7 for white males
and females, respectively. The current observation
explored the potential predictors of ESRD beginning in
childhood and found higher BMI and higher levels of
blood pressure in cases who developed ESRD compared
with the white and black children and adolescents who
did not develop ESRD. These risk factors were present
even at the childhood age but we also note black males at
the childhood age can have higher blood pressure levels
even without obesity. Such observations show the com-
plexity of understanding the early origin of ESRD and
hypertensive disease. Other exposures like high dietary
sodium and low potassium may be contributing factors to
the development and acceleration of early hyperten-
sion[38,39]. Unfortunately, underlying, undetected
chronic kidney disease leading to ESRD cannot be
excluded. Histopathology of ESRD with hypertension and
without diabetes has shown various forms of glomerulo-
sclerosis[40]. Unfortunately the nature of renal glomeru-
lar pathology in young asymptomatic individuals with
high percentiles of blood pressure levels, still within nor-
mal ranges has not been studied.
The group of children in this study who eventually devel-
oped ESRD is somewhat unusual when compared to the
general adult ESRD population on dialysis. Beginning
with a childhood population and trying to match those
developing ESRD produced essentially 50% with a clinical
etiology related to early and progressive renal disease
from secondary causes. This group included a congenital
abnormality of a single kidney, Type-I diabetes, lupus,
and HIV. This diversity in the causes of ESRD is likely
related to a selection beginning in childhood. Also, while
BMI and blood pressure levels observed are still lower
than those considered abnormal by adult standards, body
mass, weight, and blood pressure in childhood track or
persist into adulthood, and can be related to a CV-renal
burden. Thus, identifying risk factors and emphasizing
preventive measures beginning in childhood are highly
germane.
The relevance of obesity to hypertension and ESRD needs
specific emphasis. Among US children and adolescents,
overweight has reached epidemic proportions[41].
According to data from the National Health and Nutrition
Examination Surveys, overweight in children and adoles-
cents increased from 5% in 1966-1970 to 15% in 1999-
2002. Also, in the Bogalusa Heart Study, 32% of children
5 to 14 years of age and 37% of children 15-17 years of age
examined in 1992 to 1994 would have been considered
overweight based on a BMI above the 85th percentile
from 1973-1974[42]. Although a number of abnormal
risk factors have been linked to a high and increasing BMI
in childhood[4,7] the current study indicates ESRD is yet
another adverse health factor associated with childhood
body fatness. Clearly, the prevention of overweight in
children and adolescents remains an important public
health challenge in the United States. However, decreas-
ing BMI in children and young adults is a challenge. Sev-
eral studies have been conducted in an attempt to reduce
the burden of overweight and obesity. However, for the
most part, these interventions have not proven successful.
In Bogalusa, Louisiana, the "Health Ahead/Heart Smart"
Table 3: Age and age-adjusted blood pressure, body mass index, and plasma glucose of ESRD cases with an un-identified cause and 
white and black non-cases.
Cases
(n = 7)
White non-cases
(n = 3012)
Black non-cases
(n = 1528)
Number of study visits attended 20 6410 3749
Mean (SE)
Age, years 13.3 (0.7) 11.4 (0.1)*** 11.9 (0.1)***
SBP, mmHg† 114.5 (2.0) 103.3 (0.1)*** 103.0 (0.1)***
DBP, mmHg† 70.1 (1.8) 62.3 (0.1)*** 62.3 (0.1)***
BMI, kg/m2† 23.5 (0.8) 18.9 (0.4)*** 18.6 (0.1)***
Plasma glucose, mg/dL† 87.0 (2.7) 85.8 (0.1) 84.0 (0.2)
Abbreviations: SBP - systolic blood pressure; DBP - diastolic blood pressure; BMI - body mass index.
All cases and controls are males. All cases are black males.
† Adjusted to the age distribution of all Bogalusa Heart Study participants
* p < 0.05, ** p < 0.01, *** p < 0.001 comparing cases to controlsBMC Nephrology 2009, 10:40 http://www.biomedcentral.com/1471-2369/10/40
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program has been developed and implemented. This pro-
gram builds on more than two decade's research in creat-
ing an effective cardiovascular prevention and general
health education for children. The goal of this program is
to improve children's health and behavior using an
approach that will last their entire life. Future studies are
needed to evaluate the benefits of programs such as the
"Health Ahead/Heart Smart" program on outcomes.
There are major limitations of the current study. One lies
in the imperfect linkage between Bogalusa Heart Study
data with the USRDS which could help detect additional
individuals with ESRD. Specifically, social security num-
bers were not collected for children and adolescents at the
time of their Bogalusa Heart Study visits in the 1970s and
1980s. Therefore, linkage to the USRDS relied on the
Bogalusa Heart Study participants' names without
changes, dates of birth and early street addresses. Clearly,
the series of 15 cases being reported most likely represents
only some of the ESRD cases that have occurred among
Bogalusa Heart Study participants. Because ESRD among
young adults is rare, the threat of bias to the current results
is minimal. Perhaps an even greater limitation is the lack
of a detailed follow up from childhood to young adult-
hood when ESRD occurred. A gap occurs in most cases
between childhood risk factor surveys and hospital data.
Conclusion
The current observations provide data showing an inci-
dence of ESRD among black males higher than expected
based on the race-sex composition of the Bogalusa Heart
Study. Also, high blood pressure and BMI in childhood
were associated with the development of ESRD in adult-
hood. In children, blood pressure and BMI levels have
increased dramatically over the past 30 years. The associa-
tion of these risk factors with ESRD along with subclinical
evidence of changes to the CV renal system may account,
in part, for the increasing incidence of ESRD and point to
a critical area for prevention.
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